Artículo
Vaccine strategies against Babesia bovis based on prime-boost immunizations in mice with modified vaccinia Ankara vector and recombinant proteins
Jaramillo Ortiz, José Manuel; del Medico Zajac, Maria Paula; Zanetti, Flavia Adriana
; Molinari, Maria Paula
; Gravisaco, María José; Calamante, Gabriela; Wilkowky, Silvina Elizabeth
Fecha de publicación:
23/06/2014
Editorial:
Elsevier
Revista:
Vaccine
ISSN:
0264-410X
Idioma:
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
In this study, a recombinant modified vaccinia virus Ankara vector expressing a chimeric multi-antigenwas obtained and evaluated as a candidate vaccine in homologous and heterologous prime-boost immu-nizations with a recombinant protein cocktail. The chimeric multi-antigen comprises immunodominantB and T cell regions of three Babesia bovis proteins. Humoral and cellular immune responses were eval-uated in mice to compare the immunogenicity induced by different immunization schemes. The bestvaccination scheme was achieved with a prime of protein cocktail and a boost with the recombinantvirus. This scheme induced high level of specific IgG antibodies and secreted IFN and a high degree ofactivation of IFN+CD4+and CD8+specific T cells. This is the first report in which a novel vaccine can-didate was constructed based on a rationally designed multi-antigen and evaluated in a prime-boostregime, optimizing the immune response necessary for protection against bovine babesiosis.
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(ICT - MILSTEIN)
Articulos de INST.DE CS. Y TECNOLOGIA "DR. CESAR MILSTEIN"
Articulos de INST.DE CS. Y TECNOLOGIA "DR. CESAR MILSTEIN"
Articulos(SEDE CENTRAL)
Articulos de SEDE CENTRAL
Articulos de SEDE CENTRAL
Citación
Jaramillo Ortiz, José Manuel; del Medico Zajac, Maria Paula; Zanetti, Flavia Adriana; Molinari, Maria Paula; Gravisaco, María José; et al.; Vaccine strategies against Babesia bovis based on prime-boost immunizations in mice with modified vaccinia Ankara vector and recombinant proteins; Elsevier; Vaccine; 32; 36; 23-6-2014; 4625-4632
Compartir
Altmétricas